Ken Valenzano, VP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), sold 5,000 shares at $12.50 ($63K) on 2015-04-15, disclosed to the SEC on 2015-04-17.
Scheduled sale ($62k) by VP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2015-05-12 | $141K | — | Filing → |
| FOLD | SELL | 2015-03-25 | $91K | — | Filing → |
| FOLD | SELL | 2015-03-24 | $150K | — | Filing → |